Has Abhishek Kumar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $468,842 in general payments to Abhishek Kumar, MD across 506 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abhishek Kumar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abhishek Kumar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abhishek Kumar, MD

Vascular & Interventional Radiology · Philadelphia, PANPI 1427463058

Payments from drug & device makers

$468,842in general payments, 2019–2025

Across 506 payments — averaging $926.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$433K
Biocompatibles, Inc.$11K
Guerbet LLC$8K
Balt USA, LLC$5K
Bard Peripheral Vascular, Inc.$4K
Siemens Medical Solutions USA, Inc.$2K
plus $6K from 18 others

What the payments were for

Consulting fees$55,86514%
Speaking & faculty fees$298,78173%
Travel & lodging$37,9529%
Food & beverage$17,5124%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	408	$432,676
Biocompatibles, Inc.	10	$10,657
Guerbet LLC	3	$8,261
Balt USA, LLC	16	$5,167
Bard Peripheral Vascular, Inc.	6	$3,840
Siemens Medical Solutions USA, Inc.	1	$2,000
Penumbra, Inc.	2	$1,251
Inari Medical, Inc.	11	$1,133
Medtronic(2 entities)	15	$1,039
Cardiovascular Systems Inc.	7	$578
Angiodynamics, Inc.	5	$442
Trisalus Life Sciences, Inc.	2	$345
Stryker	2	$296
Imperative Care, Inc	2	$253
Okami Medical, Inc.	1	$215
Abbott	2	$178
Argon Medical Devices, Inc.	3	$144
BTG International Canada Inc.	1	$125
Alphatec Spine, Inc	1	$57
Cordis US CORP.	2	$48
Globus Medical	1	$44
Sirtex Medical Inc	2	$41
Cook Medical LLC	2	$34
Terumo Medical Corporation	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TheraSphere Y90 Glass Microspheres 10 GBq$190,132
GENERAL EMBOLICS$49,959
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$21,988
GENERAL - THERAPIES$17,728
THERASPHERE-BIO$10,763
OBSIDIO$9,892
GENERAL - IO ABLATION$4,901
Lipiodol$4,128
Prestige Coil System$3,598
EMBOLD Fibered$3,103
Indigo System$1,200
FLOWTRIEVER CATHETER, S$847
CT THROMBECTOMY SYSTEM KIT$847
Diamondback Peripheral$528
Ballast 088 Long Sheath$377
TRINAV INFUSION SYSTEM$345
AlphaVac$315
THERASPHERE$300
FlowTriever$262
SYMPHONY CATHETER$253

How this compares

$468,842 in reported general payments places this provider in the 95th percentile of 223 vascular & interventional radiology providers in Pennsylvania.

See all vascular & interventional radiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$217,810

Medicare patients

Services billed

348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	20	$71
Levofloxacin	20	$42
Oxycodone Hcl	19	$41

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Philadelphia

Michael SoulenPhiladelphia$3.6M
Timothy ClarkPhiladelphia$841K
Scott TrerotolaPhiladelphia$786K
James McGuckinPhiladelphia$677K
Carin GonsalvesPhiladelphia$555K
Gregory NadolskiPhiladelphia$423K
Kevin AntonPhiladelphia$353K
Jason HoffmannPhiladelphia$241K
Colette ShawPhiladelphia$162K
Noor AhmadPhiladelphia$122K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →